Testimonials

Money Matters magazine has named us in its top 50 ‘sound investments’ two years running.

A 2006 Eduwatch survey of postgraduate students placed us in the top 10 of most desirable private sector employers for science graduates.

Since 2003 New Eden’s projects have generated over 1,500 column inches in the national press.

In 2007, a major industry survey conducted by U-Know gave us an ‘excellent’ ranking for our standards of integrity and environmental awareness.

Gull’s Medical Journal voted Lexaran (developed by New Eden) the most significant new medical product of 2005.

Biotech Facilities

ABOUT US

"We see ourselves at one end of a continuum, with patients and communities at the other. The work we do has to be the beginning of a process which results in an ultimate benefit for those patients and communities."

Dr John Winters, CEO

New Eden is one of the fastest growing research institutions in the UK. Thanks to a number of recent breakthroughs in the field of biotechnology conducted here in Cardiff (the home of New Eden since 2005), we have been able to double our research staff in the past five years. We are now the leading recruiter of graduates into research roles in Wales and in the top 100 worldwide.

We feel we are entitled to regard ourselves as at the cutting edge of biotechnological research. We hold several major development contracts, have introduced eight new products to the market in the past year alone (including Voronin, Beroxirac and Raitac) and have more than 30 projects in development right now.

New Eden welcomes new investment in its activities. We have a record of providing strong returns to our investors and schemes for backing specific projects are available. Contact us if you would like to discuss investing in us.